ITGA3 and metastatic neoplasm: Studies evaluating the expression of integrin alpha 3 in primary colon cancer and its respective metastases in the liver have shown that almost 27.5% of primary tumors presented with increased expression of integrin alpha 3 relative to the metastatic tumor.